We report the synthesis, biological evaluation, and structural study of a series of substituted heteroaryl-pyrazole carboxylic acid derivatives. These compounds have been developed as inhibitors of specific isoforms of carbonic anhydrase (CA), with potential as prototypes of a new class of chemotherapeutics. Both X-ray crystallography and computational modeling provide insights into the CA inhibition mechanism. Results indicate that this chemotype produces an indirect interference with the zinc ion, thus behaving differently from other related nonclassical inhibitors. Among the tested compounds, 2c with Ki= 0.21 μM toward hCA XII demonstrated significant antiproliferative activity against hypoxic tumor cell lines. Taken together, the results thus provide the basis of structural determinants for the development of novel anticancer agents.

Exploring Heteroaryl-pyrazole Carboxylic Acids as Human Carbonic Anhydrase XII Inhibitors / Cadoni, Roberta; Pala, Nicolino; Lomelino, Carrie; Mahon, Brian P.; Mckenna, Robert; Dallocchio, Roberto Nico; Dessã¬, Alessandro; Carcelli, Mauro; Rogolino, Dominga; Sanna, Vanna Annunziata; Rassu, Mauro; Iaccarino, Ciro; Vullo, Daniela; Supuran, Claudiu T.; Sechi, Mario. - In: ACS MEDICINAL CHEMISTRY LETTERS. - ISSN 1948-5875. - 8:9(2017), pp. 941-946. [10.1021/acsmedchemlett.7b00229]

Exploring Heteroaryl-pyrazole Carboxylic Acids as Human Carbonic Anhydrase XII Inhibitors

CADONI, Roberta;PALA, Nicolino;DALLOCCHIO, Roberto Nico;SANNA, Vanna Annunziata;RASSU, Mauro;IACCARINO, Ciro;SECHI, Mario
2017-01-01

Abstract

We report the synthesis, biological evaluation, and structural study of a series of substituted heteroaryl-pyrazole carboxylic acid derivatives. These compounds have been developed as inhibitors of specific isoforms of carbonic anhydrase (CA), with potential as prototypes of a new class of chemotherapeutics. Both X-ray crystallography and computational modeling provide insights into the CA inhibition mechanism. Results indicate that this chemotype produces an indirect interference with the zinc ion, thus behaving differently from other related nonclassical inhibitors. Among the tested compounds, 2c with Ki= 0.21 μM toward hCA XII demonstrated significant antiproliferative activity against hypoxic tumor cell lines. Taken together, the results thus provide the basis of structural determinants for the development of novel anticancer agents.
Exploring Heteroaryl-pyrazole Carboxylic Acids as Human Carbonic Anhydrase XII Inhibitors / Cadoni, Roberta; Pala, Nicolino; Lomelino, Carrie; Mahon, Brian P.; Mckenna, Robert; Dallocchio, Roberto Nico; Dessã¬, Alessandro; Carcelli, Mauro; Rogolino, Dominga; Sanna, Vanna Annunziata; Rassu, Mauro; Iaccarino, Ciro; Vullo, Daniela; Supuran, Claudiu T.; Sechi, Mario. - In: ACS MEDICINAL CHEMISTRY LETTERS. - ISSN 1948-5875. - 8:9(2017), pp. 941-946. [10.1021/acsmedchemlett.7b00229]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11388/198066
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 22
  • ???jsp.display-item.citation.isi??? 20
social impact